Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate. [electronic resource]
Producer: 20150409Description: 103-9 p. digitalISSN:- 1941-2703
- Administration, Inhalation
- Adrenergic beta-2 Receptor Agonists -- administration & dosage
- Aerosols
- Aged
- Aged, 80 and over
- Albuterol -- administration & dosage
- Bronchodilator Agents -- administration & dosage
- Cross-Over Studies
- Drug Delivery Systems -- instrumentation
- Ethanolamines -- administration & dosage
- Female
- Forced Expiratory Volume
- Formoterol Fumarate
- Humans
- Inhalation -- drug effects
- Lung -- drug effects
- Male
- Middle Aged
- Nebulizers and Vaporizers
- New Hampshire
- Patient Preference
- Powders
- Prospective Studies
- Pulmonary Disease, Chronic Obstructive -- diagnosis
- Salmeterol Xinafoate
- Single-Blind Method
- Time Factors
- Treatment Outcome
- Vital Capacity
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.